Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Predictors for Adverse Events in EVAR

University of Thessaly

Status: Completed

Conditions: Inflammation in EVAR

Treatments: Other: NLR

Study type: Observational

Funder types: Other

Identifiers

NCT04254211

NLR, PLR in EVAR

Details and patient eligibility

About

This study investigated the association of chronic inflammatory markers with the clinical outcome after endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm.

Full description

The study included 230 consecutive AAA patients, treated electively by EVAR from March 2016 to February 2019. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively.Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause.

Enrollment: 230 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• AAA
• Elective
• EVAR

Exclusion criteria

• Emergency
• Open surgery

Trial design

230 participants in 1 patient group

EVAR

Description:

Patinets with AAA, treated electively by EVAR. The values of simple inflammatory markers,neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), were measured pre- and postoperatively. Adverse events included any major adverse cardiovascular events (MACE), acute kidney injury and death from any cause

Treatment:

Other: NLR